Premier Pharmacy Labs recalls products after FDA inspection
The company has announced a recall of products which were intended to be sterile after a lack of sterility assurance.
List view / Grid view
The company has announced a recall of products which were intended to be sterile after a lack of sterility assurance.
A multi-company system to improve traceability of pharmaceutical products is newly supported by the FDA.
Although good auditors base conclusions on facts, emotions will play an important part in how they perceive your company, your leadership and your quality culture.
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.
Comparative human in-vivo study of an immediate release tablet over-encapsulated by gelatin and hydroxypropyl methyl cellulose capsules –impact of dissolution rate on bioequivalence.
ISO/IEC 17025:2017, general requirements for the competence of testing and calibration laboratories, is the international reference for laboratories carrying out calibration and testing activities around the world.
A drug alert has been issued for two batches of paracetamol tablets found to have discolourations due to fungi.
How an inline vial management device is able to reject, retrieve for sampling, or reintroduce vials automatically during the loading/unloading process into pharmaceutical freeze-dryers.
Overview on how ionBench products can help LC/MS users with dedicated furniture for their instrumentation
A treatment for amyloidosis has been pulled from clinical trials after failing to reach endpoints.
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
Walmart has joined a consortium that’s attempting to build a blockchain for tracking pharmaceutical supply chains.
Heritage has recalled two of its injectable treatments after microbial growths were found.
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
FDA sends warning to Petra Hygienic Systems Int LTD after they find violations of current good manufacturing practices (cGMPs).